New Releases from NCBI BookshelfCabotegravir (Apretude): Indication: For at-risk adults and adolescents aged 12 years and older and weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection: CADTH Reimbursement Recommendation [Internet].​Cabotegravir (Apretude): Indication: For at-risk adults and adolescents aged 12 years and older and weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection: CADTH Reimbursement Recommendation [Internet].